- March 18, 2014 at 1:43 am #116999
dvjorgeParticipantTopics: 283Replies: 1368
I know it since long time but wanted to bring the article to all you.
Pharmaceutical probiotic may assist or help the immune system and the gut microbiota. However, they are aerobic or facultative anaerobic. They don’t offer real protection against candida colonization.
Our defense against intestinal yeast colonization is the obligated anaerobic bacterial flora.
Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans.
Kennedy MJ, Volz PA.
Mice were treated orally with various antibiotics to determine which members of the indigenous intestinal microflora normally suppress Candida albicans colonization and dissemination from the gastrointestinal (GI) tract. The mice were given penicillin, clindamycin, vancomycin, erythromycin, or gentamicin for 3 days, and then challenged orally with C. albicans. Penicillin, clindamycin, and vancomycin, but not gentamicin or erythromycin, decreased the total anaerobic bacterial populations in the animals ceca, and increased the enteric bacilli population levels. All three of the former antibiotics allowed C. albicans to proliferate in the gut and, subsequently, disseminate from the GI tract to visceral organs. The ability of C. albicans to associate with intestinal mucosal surfaces was also tested. It was found that antibiotics which reduced anaerobic population levels, but not enteric bacilli or aerobes, also predisposed animals to mucosal association by C. albicans. It is suggested that the strictly anaerobic bacterial populations which predominate in the gut ecosystem are responsible for the inhibition of C. albicans adhesion, colonization and dissemination from the GI tract.March 18, 2014 at 3:18 am #117012
Vegan CatladyMemberTopics: 34Replies: 626
I am not very smart when it comes to bacteria,good and bad, and so to help me understand this-
how do we encourage anaerobic bacteria ?
The topic ‘Anaerobic flora, the real protection mechanism .!’ is closed to new replies.